Literature DB >> 23648388

Association of P2X7 receptor gene polymorphisms with sporadic Parkinson's disease in a Han Chinese population.

Hongxin Liu1, Xun Han, Yongsheng Li, Haiqiang Zou, Anmu Xie.   

Abstract

Previous studies have indicated that genetic polymorphisms in the P2X7 receptors may influence the occurrence and development of sporadic Parkinson's diseases (PD). In our study, two DNA polymorphisms at P2X7 receptor gene: 1513A>C (rs3751143) and 1729T>A (rs1653624) were examined by PCR-RFLP analysis in 285 sporadic patients and 285 healthy controls in Han Chinese population. For 1513A>C polymorphism, there were significant differences in genotype distribution in PD group and late-onset PD (LOPD) group relative to the control groups respectively (P=0.015 and P=0.032, respectively), as well as between male PD and the controls subgroup (P=0.031). However, there were no significant differences in the genotype and allele frequencies of 1729T>A polymorphism between groups. Our study revealed that the P2X7 receptors 1513A>C polymorphism is a risk factor for sporadic PD, LOPD and male PD in Han Chinese population, while 1729T>A polymorphism is not significantly associated with Parkinson's disease.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23648388     DOI: 10.1016/j.neulet.2013.04.049

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  10 in total

1.  Identification of rs11615992 as a novel regulatory SNP for human P2RX7 by allele-specific expression.

Authors:  Tao Peng; Li Zhong; Jing Gao; Zhu Wan; Wei-Ping Fu; Chang Sun
Journal:  Mol Genet Genomics       Date:  2019-08-13       Impact factor: 3.291

Review 2.  Purinergic Receptors in Basal Ganglia Diseases: Shared Molecular Mechanisms between Huntington's and Parkinson's Disease.

Authors:  Talita Glaser; Roberta Andrejew; Ágatha Oliveira-Giacomelli; Deidiane Elisa Ribeiro; Lucas Bonfim Marques; Qing Ye; Wen-Jing Ren; Alexey Semyanov; Peter Illes; Yong Tang; Henning Ulrich
Journal:  Neurosci Bull       Date:  2020-10-07       Impact factor: 5.203

Review 3.  P2X and P2Y receptors—role in the pathophysiology of the nervous system.

Authors:  Kamila Puchałowicz; Maciej Tarnowski; Irena Baranowska-Bosiacka; Dariusz Chlubek; Violetta Dziedziejko
Journal:  Int J Mol Sci       Date:  2014-12-18       Impact factor: 5.923

4.  Association Between P2RX7 Gene and Hepatocellular Carcinoma Susceptibility: A Case-Control Study in a Chinese Han Population.

Authors:  Shaobo Duan; Jie Yu; Zhiyu Han; Zhigang Cheng; Ping Liang
Journal:  Med Sci Monit       Date:  2016-06-06

5.  D-serine in the midbrain periaqueductal gray contributes to morphine tolerance in rats.

Authors:  Song Cao; Zhi Xiao; Mengjie Sun; Youyan Li
Journal:  Mol Pain       Date:  2016-05-12       Impact factor: 3.395

6.  Inhibiting purinergic P2X7 receptors with the antagonist brilliant blue G is neuroprotective in an intranigral lipopolysaccharide animal model of Parkinson's disease.

Authors:  Xin-Hong Wang; Xin Xie; Xiao-Guang Luo; Hong Shang; Zhi-Yi He
Journal:  Mol Med Rep       Date:  2016-12-23       Impact factor: 2.952

Review 7.  P2X7 Variants in Oncogenesis.

Authors:  Anna Pegoraro; Elena De Marchi; Elena Adinolfi
Journal:  Cells       Date:  2021-01-19       Impact factor: 6.600

8.  Antagonistic Roles of P2X7 and P2Y2 Receptors in Neurodegenerative Diseases.

Authors:  Talita Glaser; Ágatha Oliveira-Giacomelli; Lyvia Lintzmaier Petiz; Deidiane Elisa Ribeiro; Roberta Andrejew; Henning Ulrich
Journal:  Front Pharmacol       Date:  2021-04-12       Impact factor: 5.810

Review 9.  Purinergic Receptors in Neurological Diseases With Motor Symptoms: Targets for Therapy.

Authors:  Ágatha Oliveira-Giacomelli; Yahaira Naaldijk; Laura Sardá-Arroyo; Maria C B Gonçalves; Juliana Corrêa-Velloso; Micheli M Pillat; Héllio D N de Souza; Henning Ulrich
Journal:  Front Pharmacol       Date:  2018-04-10       Impact factor: 5.810

Review 10.  Purinergic Signalling in Parkinson's Disease: A Multi-target System to Combat Neurodegeneration.

Authors:  Adrián Tóth; Zsófia Antal; Dániel Bereczki; Beáta Sperlágh
Journal:  Neurochem Res       Date:  2019-05-04       Impact factor: 3.996

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.